GB202016957D0 - Beneficial treatment - Google Patents

Beneficial treatment

Info

Publication number
GB202016957D0
GB202016957D0 GBGB2016957.9A GB202016957A GB202016957D0 GB 202016957 D0 GB202016957 D0 GB 202016957D0 GB 202016957 A GB202016957 A GB 202016957A GB 202016957 D0 GB202016957 D0 GB 202016957D0
Authority
GB
United Kingdom
Prior art keywords
beneficial treatment
beneficial
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2016957.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wista Laboratories Ltd
Original Assignee
Wista Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wista Laboratories Ltd filed Critical Wista Laboratories Ltd
Priority to GBGB2016957.9A priority Critical patent/GB202016957D0/en
Publication of GB202016957D0 publication Critical patent/GB202016957D0/en
Priority to MX2022013884A priority patent/MX2022013884A/en
Priority to PCT/EP2021/061485 priority patent/WO2021224146A1/en
Priority to CA3181388A priority patent/CA3181388A1/en
Priority to JP2022567338A priority patent/JP2023524146A/en
Priority to BR112022022322A priority patent/BR112022022322A2/en
Priority to AU2021268465A priority patent/AU2021268465A1/en
Priority to CN202180043776.XA priority patent/CN115916211A/en
Priority to EP21724580.2A priority patent/EP4146225A1/en
Priority to KR1020227042296A priority patent/KR20230012515A/en
Priority to US17/922,886 priority patent/US20230158040A1/en
Priority to TW110116178A priority patent/TW202200149A/en
Ceased legal-status Critical Current

Links

GBGB2016957.9A 2020-05-05 2020-10-26 Beneficial treatment Ceased GB202016957D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB2016957.9A GB202016957D0 (en) 2020-10-26 2020-10-26 Beneficial treatment
US17/922,886 US20230158040A1 (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of hypoxemia
JP2022567338A JP2023524146A (en) 2020-05-05 2021-04-30 Methylthioninium compounds used to treat hypoxemia
PCT/EP2021/061485 WO2021224146A1 (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of hypoxemia
CA3181388A CA3181388A1 (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of hypoxemia
MX2022013884A MX2022013884A (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of hypoxemia.
BR112022022322A BR112022022322A2 (en) 2020-05-05 2021-04-30 METHYLTHIONIUM COMPOUNDS FOR USE IN THE TREATMENT OF HYPOXEMIA
AU2021268465A AU2021268465A1 (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of hypoxemia
CN202180043776.XA CN115916211A (en) 2020-05-05 2021-04-30 Methylthioninium compounds for the treatment of hypoxemia
EP21724580.2A EP4146225A1 (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of hypoxemia
KR1020227042296A KR20230012515A (en) 2020-05-05 2021-04-30 beneficial treatment methods
TW110116178A TW202200149A (en) 2020-05-05 2021-05-05 Beneficial treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2016957.9A GB202016957D0 (en) 2020-10-26 2020-10-26 Beneficial treatment

Publications (1)

Publication Number Publication Date
GB202016957D0 true GB202016957D0 (en) 2020-12-09

Family

ID=73727053

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2016957.9A Ceased GB202016957D0 (en) 2020-05-05 2020-10-26 Beneficial treatment

Country Status (1)

Country Link
GB (1) GB202016957D0 (en)

Similar Documents

Publication Publication Date Title
GB202108224D0 (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202016957D0 (en) Beneficial treatment
GB202116743D0 (en) Treatment
GB202114373D0 (en) Treatment
GB202109812D0 (en) Treatment
GB202109815D0 (en) Treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202103122D0 (en) Treatment
GB202102488D0 (en) Treatment
GB202102369D0 (en) Treatment
GB202102366D0 (en) Treatment
GB202102410D0 (en) Treatment
GB202102373D0 (en) Treatment
GB202101897D0 (en) Treatment
GB202101875D0 (en) Treatment
GB202101211D0 (en) Treatment
GB202101212D0 (en) Treatment
GB202101213D0 (en) Treatment
GB202101210D0 (en) Treatment
GB202100976D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)